VACCINE RESEARCH INSTITUTE OF SAN DIEGO: Form 990EZ, tax year 2019
View the entire original 990 at ProPublica ↗
- Organization
- VACCINE RESEARCH INSTITUTE OF SAN DIEGO (EIN 33-0903864)
- Tax period
- 2019-07-01 to 2020-06-30
- Filed
- 2022-05-13
- IRS object ID
- 202221339349200337
- Schema version
- 2019v5.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2022-05-13T15:40:27-07:00 | ReturnTs |
| Tax Period End | 2020-06-30 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 952076568 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Leaf & Cole LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2810 Camino Del Rio South Suite 200 | AddressLine1Txt |
| City | San Diego | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 92108 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990EZ | ReturnTypeCd |
| Tax Period Begin | 2019-07-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 330903864 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | VACCINE RESEARCH INSTITUTE OF SAN DIEGO | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | VACC | BusinessNameControlTxt |
| Phone | 8585813960 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 3030 BUNKER HILL ST | AddressLine1Txt |
| City | SAN DIEGO | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 92109 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | JOHN WELSH PHD | PersonNm |
| Person Title | CEO | PersonTitleTxt |
| Signature | 2022-05-13 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | LATONYA M KNOX | PreparerPersonNm |
| PTIN | P00513874 | PTIN |
| Phone | 6192947200 | PhoneNum |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2019 | TaxYr |
| Build TS | 2022-09-23 18:48:47Z | BuildTS |
Form 990-EZ IRS990EZ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Website Address | www.vrisd.org | WebsiteAddressTxt |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Gross Receipts | $100,099 | GrossReceiptsAmt |
| Info In Schedule O Part I | Yes (X) | InfoInScheduleOPartIInd |
| Contributions Gifts Grants Etc | $98,519 | ContributionsGiftsGrantsEtcAmt |
| Investment Income | $80 | InvestmentIncomeAmt |
| Sale Of Assets Gross | $1,500 | SaleOfAssetsGrossAmt |
| Cost Or Other Basis Expense Sale | $0 | CostOrOtherBasisExpenseSaleAmt |
| Gain Or Loss From Sale Of Assets | $1,500 | GainOrLossFromSaleOfAssetsAmt |
| Fundraising Gross Income | $0 | FundraisingGrossIncomeAmt |
| Special Events Direct Expenses | $0 | SpecialEventsDirectExpensesAmt |
| Cost Of Goods Sold | $0 | CostOfGoodsSoldAmt |
| Total Revenue | $100,099 | TotalRevenueAmt |
| Salaries Other Comp Empl Bnft | $50,785 | SalariesOtherCompEmplBnftAmt |
| Fees And Other Pymt To Ind Cntrct | $7,726 | FeesAndOtherPymtToIndCntrctAmt |
| Occupancy Rent Utlts And Maint | $49,453 | OccupancyRentUtltsAndMaintAmt |
| Printing Publications Postage | $25 | PrintingPublicationsPostageAmt |
| Other Expenses Total | $28,028 | OtherExpensesTotalAmt |
| Total Expenses | $136,017 | TotalExpensesAmt |
| Excess Or Deficit For Year | -$35,918 | ExcessOrDeficitForYearAmt |
| Net Assets Or Fund Balances BOY | $71,295 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $35,377 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part II | Yes (X) | InfoInScheduleOPartIIInd |
Cash Savings And Investments CashSavingsAndInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $69,396 | BOYAmt |
| EOY | $8,428 | EOYAmt |
Land And Buildings LandAndBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| EOY | $14,366 | EOYAmt |
Other Assets Total Detail OtherAssetsTotalDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $34,384 | BOYAmt |
| EOY | $17,256 | EOYAmt |
Form990 Total Assets Form990TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $103,780 | BOYAmt |
| EOY | $40,050 | EOYAmt |
Sum Of Total Liabilities SumOfTotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $32,485 | BOYAmt |
| EOY | $4,673 | EOYAmt |
Net Assets Or Fund Balances NetAssetsOrFundBalancesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $71,295 | BOYAmt |
| EOY | $35,377 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Primary Exempt Purpose | OUR MISSION IS SCIENTIFIC RESEARCH FOCUSING ON DEVELOPMENT OF PREVENTATIVE AND THERAPEUTIC TREATMENTS FOR BOTH INFECTIOUS (MAALARIA, HEPATITIS B AND C, AND INFLUENZA) AND NON-INFECTIOUS DISEASES (CANCER AND CARDIOVASCULAR DISEASE). | PrimaryExemptPurposeTxt |
Program Srvc Accomplishment ProgramSrvcAccomplishmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Description Program Srvc Accom | Our mission is scientific research focusing on development of preventative and therapeutic treatments for both infectious (malaria, hepatitis B and C, and influenza) and non-infectious diseases (cancer and cardiovascular disease).These studies involve the development of new cancer therapeutics as well as prophylactic and therapeutic vaccines. The goal is to bring to fruition treatments for diseases which have plagued millions of people worldwide and to share these results with the scientific community and the public.To accomplish these goals the VRISD has recruited and will continue to recruit researchers with expertise in Molecular Biology, Pharmacogenomics, Peptide Chemistry, Bioinformatics, Oncology and Immunology. These areas of expertise will allow us to gain an understanding of the host-pathogen and host-tumor interactions as they relate to effective therapeutic design. VRISD scientists are working together for the purpose of eradicating diseases that have eluded researchers and physicians in the past, with the ultimate goal of providing better health for all people worldwide. | DescriptionProgramSrvcAccomTxt |
| Grants And Allocations | $107,613 | GrantsAndAllocationsAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $107,613 | TotalProgramServiceExpensesAmt |
Officer Director Trustee Empl OfficerDirectorTrusteeEmplGrp (4 entries)
| TitleTitleTxt | Average Hrs Per Wk Devoted To PosAverageHrsPerWkDevotedToPosRt | CompensationCompensationAmt | Employee Benefit ProgramEmployeeBenefitProgramAmt | Expense Account Other AllwncExpenseAccountOtherAllwncAmt |
|---|---|---|---|---|
| JOHN WELSH PHD | ||||
| CEO | 40.00 | $56,246 | $15,690 | $3,151 |
| DAVID R MILICH PHD | ||||
| Chairman | 2.00 | $0 | ||
| RANDY HORTON | ||||
| Director | 1.00 | $0 | ||
| TERRY DILLMAN | ||||
| Director | 1.00 | $0 | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Activities Not Previously Rpt | false | ActivitiesNotPreviouslyRptInd |
| Chg Made To Orgnzng Doc Not Rpt | false | ChgMadeToOrgnzngDocNotRptInd |
| Organization Had UBI | false | OrganizationHadUBIInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Organization Dissolved Etc | false | OrganizationDissolvedEtcInd |
| Form1120 Pol Filed | false | Form1120PolFiledInd |
| Made Loans To From Officers | false | MadeLoansToFromOfficersInd |
| Tax Imposed Under IRC4911 | $0 | TaxImposedUnderIRC4911Amt |
| Tax Imposed Under IRC4912 | $0 | TaxImposedUnderIRC4912Amt |
| Tax Imposed Under IRC4955 | $0 | TaxImposedUnderIRC4955Amt |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| Tax Imposed On Organization Mgr | $0 | TaxImposedOnOrganizationMgrAmt |
| Tax Reimbursed By Organization | $0 | TaxReimbursedByOrganizationAmt |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | LEAH JOHNSON | PersonNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 3030 BUNKER HILL ST | AddressLine1Txt |
| City | SAN DIEGO | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 92109 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 8585813960 | PhoneNum |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Foreign Financial Account | false | ForeignFinancialAccountInd |
| Foreign Office | false | ForeignOfficeInd |
| Donor Advised Fnds | false | DonorAdvisedFndsInd |
| Operate Hospital | false | OperateHospitalInd |
| Tanning Services Provided | false | TanningServicesProvidedInd |
| Related Organization Ctrl Ent | false | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | false | TransactionWithControlEntInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | false | LobbyingActivitiesInd |
| School Operating | false | SchoolOperatingInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | false | TrnsfrExmptNonChrtblRltdOrgInd |
| Part VI Of Comp Of Hghst Pd Empl | NONE | PartVIOfCompOfHghstPdEmplTxt |
| Part VI Hghst Pd Cntrct Prof Srvc | NONE | PartVIHghstPdCntrctProfSrvcTxt |
| Filed Schedule A | Yes (true) | FiledScheduleAInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $902,931 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $1,031,384 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $767,219 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $450,609 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $98,519 | CurrentTaxYearAmt |
| Total | $3,250,662 | TotalAmt |
Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $902,931 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $1,031,384 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $767,219 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $450,609 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $98,519 | CurrentTaxYearAmt |
| Total | $3,250,662 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $2,262,737 | SubstantialContributorsTotAmt |
| Public Support Total170 | $987,925 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $160 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $212 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $224 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $205 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $80 | CurrentTaxYearAmt |
| Total | $881 | TotalAmt |
Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $3,251,543 | TotalSupportAmt |
| Public Support CY170 | 0.30380 | PublicSupportCY170Pct |
| Public Support PY170 | 0.41000 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests PY170 | Yes (X) | ThirtyThrPctSuprtTestsPY170Ind |
| Facts And Circumstances Test | Current Year Facts and Circumstances: From 2017 through 2022, VRISD scientists applied for 29 grants from the National Institutes of Health, several from the Department of Defense, and published 45 papers, over topics ranging from Alzheimers disease to prostate cancer. Obtaining funding has been very challenging, and we have not been funded by a public grant since 2017. The organization had hoped that funding from Pellficure Inc. would help bridge the gap between NIH and DOD grants. From the point of view of public benefit, Pellficure Inc. had defined research goals and many of the staff of VRISD worked toward accomplishing those goals, and findings from those studies have been published in publicly accessible literature, thereby accruing public benefit. That work focused on studying the properties of a natural product, plumbagin, that many scientists think may have therapeutic value in treating cancer. Pellficure has a limited intellectual property position regarding plumbagins use in treating prostate cancer. The basic science worked out along the way and published was not performed to support Pellficures property goals. The organization also worked on several projects unrelated to the objectives of Pellficure Inc., including a project to develop a gene signature for the adaptation of metastatic prostate cancer to bone marrow, for which a manuscript is under preparation, and which will serve as a grant application subject in the near future. The organization has also been working on a sequencing technology that was funded through 2017 by the National Cancer Center and will soon be advanced enough to request Phase II funding. While extensive efforts to achieve public funding during the Pellficure period were unsuccessful, the focus and emphasis continues to be to perform basic publicly funded research on important public health problems, and there are several projects in mid-stage development that will develop into NIH, NCI, and DOD grant applications this year, as well as possibly smaller funding sources. | FactsAndCircumstancesTestTxt |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (17 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Other Expenses.1005 | Travel $18 |
| Other Expenses.1007 | Conferences, Conventions, and Meetings $368 |
| Other Expenses.1008 | Interest $298 |
| Other Expenses.1009 | Depreciation $845 |
| Other Expenses.1012 | Insurance $9615 |
| Other Expenses.1 | PATENT, LEGAL & TAXES $4559 |
| Other Expenses.2 | SUPPLIES $4315 |
| Other Expenses.3 | RELOCATION COSTS $3689 |
| Other Expenses.4 | TELEPHONE $2676 |
| Other Expenses.5 | LICENSES & PERMITS $1040 |
| Other Expenses.6 | ANIMAL COSTS $559 |
| Other Expenses.7 | BANK & CREDIT CARD FEES $46 |
| Other Assets.1005 | Accounts Receivable - Beginning $25720 Accounts Receivable - Ending $12344 |
| Other Assets.1011 | Prepaid Expenses and Deferred Charges - Beginning $3752 Prepaid Expenses and Deferred Charges - Ending $0 |
| Other Assets.1 | DEPOSITS - Beginning $4912 DEPOSITS - Ending $4912 |
| Total Liabilities.1001 | Accounts Payable and Accrued Expenses - Beginning $12594 Accounts Payable and Accrued Expenses - Ending $4673 |
| Total Liabilities.1 | OTHER LIABILITIES - Beginning $19891 OTHER LIABILITIES - Ending $0 |
Comments